|
Volumn 40, Issue 3, 2013, Pages 307-323
|
Treatment optimization in MS: Canadian MS Working Group updated recommendations
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOLOGIC FACTOR;
CANADA;
DISABILITY;
DISEASE MANAGEMENT;
HUMAN;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRACTICE GUIDELINE;
SECONDARY PREVENTION;
CANADA;
DISABILITY EVALUATION;
DISEASE MANAGEMENT;
HUMANS;
IMMUNOLOGIC FACTORS;
MAGNETIC RESONANCE IMAGING;
MULTIPLE SCLEROSIS;
PRACTICE GUIDELINES AS TOPIC;
SECONDARY PREVENTION;
|
EID: 84883742251
PISSN: 03171671
EISSN: None
Source Type: Journal
DOI: 10.1017/S0317167100014244 Document Type: Review |
Times cited : (173)
|
References (0)
|